SYRE
#1070
Spyre Therapeutics, Inc. - Common Stock
87.2 5 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.23%
Variación mensual
-16.86%
Variación en los últimos 6 meses
+116.29%
Cambio anual
+264.91%
Cierres anteriores
87.0 5
Open
87.2 5
Mínimo
87.2 5
Máximo
87.2 5
Volumen
131
Financials
- Market Capitalization 7.69 B
- Employee 112
- Founded 2013
- CEO N/A
- Website www.spyre.com
- Headquarter Delaware, United States
- FIGI BBG0067L94B2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-44.84
Relación precio/flujo de caja
411.15
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1018 |  APGE Apogee Therapeutics, Inc. - Common Stock | 135.07 USD | -0.01% | +0.09% | +0.65% | +152.04% | 8.40 B USD | ||
| 1048 |  IMVT Immunovant, Inc. - Common Stock | 39.12 USD | -0.94% | -9.59% | -1.54% | +103.64% | 8.08 B USD | ||
| 1099 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 104.89 USD | -0.50% | -4.83% | -5.36% | -4.91% | 7.22 B USD | ||
| 1133 |  SRRK Scholar Rock Holding Corporation - Common Stock | 55.94 USD | -0.29% | -4.78% | +16.37% | +86.34% | 6.81 B USD |